Medicines & Pharmaceutical Access
Drug prices, availability, and the rules around them across borders -- why the same medicine costs several times more in one country than another, generic and biosimilar substitution, shortages and supply-chain disruption, prescription and import rules for travellers, and the counterfeit-medicine risk in less regulated markets.

Medicines & Pharmaceutical Access
Europe's Critical Medicines List Guarantees No Supply
The EU's critical medicines list covers 270+ active substances -- amoxicillin, insulin and paracetamol among them -- but the EMA says inclusion does not guarantee supply, and the Critical Medicines Act meant to change that is agreed, not yet in force.
10 min read
